19.7 months; HR 0.80; p = 0.018) and a favorable trend in OS (54.3 vs. 48.3 months) compared to those receiving the NACT-first sequence [ 17 ].
← all excerpts
Heterogeneity in Stage IV Ovarian Cancer: Survival Trends in Patients Presenting with Sister Mary Joseph's Nodule.
3
—
—
The sentences
Although differences in RFS and OS between the two groups did not reach statistical significance, survival outcomes in patients presenting with SMJN appeared numerically more favorable in this exploratory analysis.
Patients with a Sister Mary Joseph nodule showed a trend toward better survival outcomes.